KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Other Non-Current Liabilities (2016 - 2025)

CareDx's Other Non-Current Liabilities history spans 12 years, with the latest figure at $161000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 75.04% year-over-year to $161000.0; the TTM value through Dec 2025 reached $161000.0, down 75.04%, while the annual FY2025 figure was $161000.0, 75.04% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $161000.0 at CareDx, down from $636000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $97.7 million in Q1 2024 and bottomed at $25000.0 in Q1 2023.
  • The 5-year median for Other Non-Current Liabilities is $252000.0 (2022), against an average of $15.7 million.
  • The largest annual shift saw Other Non-Current Liabilities skyrocketed 390644.0% in 2024 before it crashed 99.84% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $139000.0 in 2021, then soared by 79.14% to $249000.0 in 2022, then soared by 888.35% to $2.5 million in 2023, then plummeted by 73.79% to $645000.0 in 2024, then crashed by 75.04% to $161000.0 in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Other Non-Current Liabilities are $161000.0 (Q4 2025), $636000.0 (Q2 2025), and $160000.0 (Q1 2025).